Spain's Prince and Princess of Asturias visit Cinfa facility
Cinfa eyes growth into regional markets
Dubai, June 17, 2013
Cinfa, the UAE’s newest provider of European-standard medicines, plans to grow into other regional markets in future, its director said.
“Cinfa’s extensive drug portfolio comprises more than 120 active ingredients and 336 presentations, covering more than 35 major therapeutical areas and conditions, including hypertension and diabetes,” said Khalid Amin, regional director of Cinfa in the UAE.
“We now have products in the market to address the need for more quality choice in medicine in the UAE, and we are using the country as our springboard for growth into other regional markets,” he added.
One of Cinfa’s Spanish manufacturing facilities was recently endorsed with a high-level visit from the country’s royal family.
Accompanied by government officials and dignitaries, the Prince and Princess of Asturias took time last week to view the state-of-the-art facilities at the Cinfa headquarters, located in Navarre, Spain.
Cinfa is currently engaged in a regional expansion programme, with its entrance into the GCC region having taken place in April of this year, during which Enrique Ordieres, president of Cinfa, met with the Spanish Ambassador to the UAE Eugenio Salarich, along with senior health officials and preeminent healthcare professionals.
Salarich said they were proud to have Cinfa act as an ambassador for Spanish business through its recent expansion into the region via UAE.
Cinfa is bringing world-class levels of drug manufacturing to the GCC region at a time when demand for greater choice in pharmaceutical products in increasing.
The need for a greater volume and choice of medications in the UAE is also being fuelled by the increasing prevalence of non-communicable diseases across the region, with conditions such as obesity, hypertension, and type-2 diabetes registering an all-time high.
The World Health Organization’s figures show that a third of adults in the country are obese, with one out of five living with diabetes.
For the next three years, the planned investment is nearly $86 million - an increase of 60 per cent compared to the last three years. – TradeArabia News Service